Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Uterine Cervical Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Medulloblastoma 4Lung Neoplasms 4Neuroblastoma 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Oropharyngeal Neoplasms 2Ganglioneuroblastoma 2Carcinoma, Transitional Cell 2Vaginal Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Tongue Neoplasms 1Teratoma 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Recurrent Uterine Corpus Carcinoma 1Prostatic Neoplasms 1PRETEXT I Hepatoblastoma 1Osteosarcoma 1Neoplasms, Germ Cell and Embryonal 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Mesothelioma, Malignant 1Mesothelioma 1Lymphoid Interstitial Pneumonia 1Locally Advanced Cervical Adenocarcinoma 1Laryngeal Neoplasms 1

Interventions

Gemcitabine 12Mitomycin 11Cisplatin 10Carboplatin 8pembrolizumab 7Docetaxel 4toripalimab 3avelumab 3atezolizumab 3Paclitaxel 3sacituzumab govitecan 2disitamab vedotin 2Taxes 2Specimen Handling 2Platinum 2Magnetic Resonance Spectroscopy 2Injections 21,2-diaminocyclohexaneplatinum II citrate 2vinflunine 1valrubicin 1tislelizumab 1lenvatinib 1eribulin 1epacadostat 1enfortumab vedotin 1durvalumab 1dodecyl maltoside 1Vitamin B 12 1Standard of Care 1Ramucirumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Carcinoma, Transitional Cell × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT06524544 2026-06-02

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

National Cancer Institute (NCI)

Phase 3 Recruiting
320 enrolled
Genitourinary

Carcinoma, Transitional Cell

NCT00942331 2023-10-16

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

National Cancer Institute (NCI)

Phase 3 Completed
506 enrolled 13 charts
Genitourinary

Carcinoma, Transitional Cell, Prostatic Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡